Press release
According to DelveInsight, the Allergic Rhinitis market in 7MM is expected to witness a major change in the study period 2019-2032
Allergic Rhinitis market
The Allergic Rhinitis market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also, the launch of upcoming devices during the forecast period. Moreover, advances in disease mechanisms have yielded new diagnostic and treatment approaches, opening avenues to better treatment interventions.
Key Takeaways from Allergic Rhinitis Market Report
• Allergic Rhinitis market is expected to grow significantly owing to an increase in upcoming novel treatment options, increasing market size due to increasing prevalence, increasing global healthcare investment and funding, increasing pollutants in the environment, and the ongoing development of precision medicine.
• According to Centers for Disease Control and Prevention (CDC), symptoms of allergic rhinitis can occur during certain seasons or year-round, depending on the allergen, and affect as many as 60 million people per year in the United States.
• Allergic Rhinitis Market Companies included Novartis Pharmaceuticals, ALK-Abello, Torii Pharmaceutical, Stallergenes Greer, FAES Farma, Taiho Pharmaceuticals, Allergy Therapeutics, Regeneron Pharmaceuticals, AOBiome, Emergo Therapeutics, Inmunotek, and several others.
• Allergic Rhinitis Market Therapies included Zolea (Omalizumab), Odactra/Acarizax/Miticure (House dust mite allergy immunotherapy [HDM SLIT-tablet]), Grastek/Grazax (Grass pollen allergy vaccine tablet), Itulazax (SQ tree SLIT-tablet), and several others.
Download Sample Report- https://www.delveinsight.com/sample-request/allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Allergic Rhinitis Overview
Allergic rhinitis is a condition that occurs when the body (the immune system) overreacts to something in the environment (triggers). It is caused by allergens, which are usually harmless substances but trigger an allergic reaction in some people. When the symptoms occur in late summer or early fall, some people call it hay fever.
Allergic Rhinitis Epidemiology Insights
As per the DelveInsight estimates, in 2021, the total diagnosed cases of allergic rhinitis were around 99 M in the 7MM. These cases are expected to grow with a significant CAGR in the study period 2019-2032.
Allergic Rhinitis Epidemiology Segmentation in the 7MM
• Total Allergic Rhinitis Prevalent Cases
• Total Allergic Rhinitis Diagnosed Cases
• Total Allergic Rhinitis Allergen-specific Cases
• Total Allergic Rhinitis Treated Cases
• Total Allergic Rhinitis Age Group-Specific Cases
Allergic Rhinitis Treatment Landscape
The first-line treatment of allergic rhinitis involves the avoidance of relevant allergens (e.g., house dust mites, molds, pets, pollens) and irritants (e.g., tobacco smoke). Patients allergic to house dust mites should be instructed to use allergen-impermeable covers for bedding and to keep the relative humidity in the home below 50% (to inhibit mite growth).
Allergic Rhinitis Emerging Therapies
• Xoliar (Omalizumab): Novartis Pharmaceuticals
• REGN1908-1909 and REGN5713-5714-5715: Regeneron Pharmaceuticals
• MM09 and MG01: Inmunotek
Allergic Rhinitis Market Insights
Allergen-specific immunotherapy is the treatment in which a patient's immune system is rendered tolerant to an allergen by giving increasing doses of the allergen in a controlled fashion. There are two main routes by which immunotherapy is administered; subcutaneously and sublingually- Subcutaneous immunotherapy involves allergen injections at regular time intervals in a hospital by trained medical staff. With treatment lasting several years, patient commitment to attending hospital appointments is essential.
Scope of the Allergic Rhinitis Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Forecast Period- 11 Years
• Allergic Rhinitis Market Companies included Novartis Pharmaceuticals, ALK-Abello, Torii Pharmaceutical, Stallergenes Greer, FAES Farma, Taiho Pharmaceuticals, Allergy Therapeutics, Regeneron Pharmaceuticals, AOBiome, Emergo Therapeutics, Inmunotek, and several others.
• Allergic Rhinitis Market Therapies included Zolea (Omalizumab), Odactra/Acarizax/Miticure (House dust mite allergy immunotherapy [HDM SLIT-tablet]), Grastek/Grazax (Grass pollen allergy vaccine tablet), Itulazax (SQ tree SLIT-tablet), and several others.
• Market Drivers and Barriers
Request Sample Report- https://www.delveinsight.com/sample-request/allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Executive Summary of Allergic Rhinitis
3. Competitive Intelligence Analysis for Allergic Rhinitis
4. Allergic Rhinitis: Market Overview at a Glance
5. Allergic Rhinitis: Disease Background and Overview
6. Patient Journey
7. Allergic Rhinitis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Allergic Rhinitis Unmet Needs
10. Key Endpoints of Allergic Rhinitis Treatment
11. Allergic Rhinitis Marketed Products
12. Allergic Rhinitis Emerging Therapies
13. Allergic Rhinitis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Allergic Rhinitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
If you have any query related to the report? Just speak to analyst here- https://www.delveinsight.com/report-store/allergic-rhinitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Contact Us:
Yash Bhardwaj
ybhardwaj@delveinsight.com
+1(919)321-6187
www.delveinsight.com
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release According to DelveInsight, the Allergic Rhinitis market in 7MM is expected to witness a major change in the study period 2019-2032 here
News-ID: 2725487 • Views: …
More Releases from DelveInsight Business Research
Vascular Dementia Market Report 2032: Epidemiology Data, Pipeline Therapies, Lat …
DelveInsight's "Vascular Dementia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as well as the Vascular Dementia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Vascular Dementia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Vascular Dementia Market Forecast
https://www.delveinsight.com/sample-request/vascular-dementia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Limb Girdle Muscular Dystrophy Pipeline Assessment, 2024: FDA, EMA, and PMDA App …
Limb Girdle Muscular Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 25+ Limb Girdle Muscular Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Limb Girdle Muscular Dystrophy Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Limb Girdle Muscular Dystrophy Market.
The Limb Girdle Muscular Dystrophy…
RIPK1 Inhibitor Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approv …
RIPK1 Inhibitor pipeline constitutes 10+ key companies continuously working towards developing 12+ RIPK1 Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"RIPK1 Inhibitor Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the RIPK1 Inhibitor Market.
The RIPK1 Inhibitor Pipeline report embraces in-depth commercial and clinical assessment of the…
Atypical Teratoid Rhabdoid Tumors Pipeline Report, 2024 Updates : In-depth Analy …
Atypical Teratoid Rhabdoid Tumors pipeline constitutes 5+ key companies continuously working towards developing 5+ Atypical Teratoid Rhabdoid Tumors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Atypical Teratoid Rhabdoid Tumors Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Atypical Teratoid Rhabdoid Tumors Market.
The Atypical Teratoid Rhabdoid Tumors…
More Releases for Allergic
Allergic Rhinitis Pipeline involves 32+ key companies continuously working towar …
DelveInsight's 'Allergic Rhinitis Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline Allergic Rhinitis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Allergic Rhinitis pipeline domain.
Key Takeaways from the Allergic Rhinitis Pipeline Report
• DelveInsight's Allergic Rhinitis Pipeline analysis depicts a robust space with 32+ active players working to develop 32+ pipeline therapies…
Allergic Rhinitis Market 2018 by Seasonal, Perennial and Non-Allergic Rhinitis T …
The Allergic Rhinitis Treatment Market was valued at US $6.95 billion in the year 2018 and is estimated to reach US $9.66 billion by 2026, at a CAGR of 4.20%.
Allergic Rhinitis is inflammation caused inside the nose by allergen, also called as hay fever. Allergic Rhinitis develops when body’s immune system becomes sensitized and overreacts on exposure to allergens in the environment. It is mostly triggered by outdoor allergens like…
Allergic Rhinitis Market Growing CAGR of 7% with Key Type Seasonal, Perennial an …
Global Allergic Rhinitis Market to Provide Country Level Analysis of the Market with Respect to the Current Market Size and Future Growth prospect. And also Provide Insights about Factors Affecting the Market’s Growth.
Global Allergic Rhinitis Market - Scenario
The common name for allergic rhinitis is hay fever. It is diagnosed when symptoms appear which includes itchy nose, mouth, eyes, throat, skin, as well as other parts of the body; along with…
Allergic Rhinitis Market 2018 by Seasonal, Perennial and Non Allergic Rhinitis T …
The Allergic Rhinitis Market is segmented into types, by treatment and by test. The types of the allergic rhinitis includes seasonal, perennial and non-allergic rhinitis. On the basis of the treatment the segmentation is done into antihistamines, decongestants, eye drops, nasal sprays, immunotherapy, sublingual immunotherapy (SLIT) and home remedies. The antihistamine segment is further sub-segmented into drugs like allegra, clarinex, xyzal and zyrtec. The decongestants segment is also sub-segmented into…
Allergic Conjunctivitis - Pipeline Review, H2 2016
MarketResearchReports.Biz presents this most up-to-date research on "Allergic Conjunctivitis - Pipeline Review, H2 2016"
Description
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis Pipeline Review, H2 2016, provides an overview of the Allergic Conjunctivitis (Ophthalmology) pipeline landscape.
Allergic conjunctivitis occurs when the clear layer of tissue lining the eyelids and covering the white of the eye (conjunctiva) become swollen or inflamed due to a reaction to pollen, dander, mold,…
Allergic Rhinitis Market driven by the increasing incidence of allergic rhinitis
This market research report on the global allergic rhinitis market provides a comprehensive overview of the structure and the dynamics of this market. Thus, the report throws light on the factors governing the market trends in the global allergic rhinitis market. This market research report discusses the demand drivers and the various challenges facing the industry. Historical and contemporary data as included in the research study provide a strong foundation…
